Reaffirming the freedom to decide and expressing continued support for medication abortion access.

HRES 65 is a non-binding House resolution affirming existing medication abortion access and addressing concerns about the Comstock Act. It specifically references a December 2022 Department of Justice memo confirming that federal law does not prohibit mailing abortion medications like mifepristone when sent without intent to violate the law. The resolution condemns restrictions on reproductive health care access, including medication abortion, and rejects efforts to misuse the Comstock Act to threaten such services. As a symbolic statement (not new legislation), it expresses congressional support for current legal access to medication abortion without creating new policy changes.